2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC871
Submitter : Ms. Pat LeMond Date & Time: 10/17/2005 10:10:01
Organization : Ms. Pat LeMond
Category : Individual Consumer
Issue Areas/Comments
GENERAL
GENERAL
See Attachment:

As you review the data on Plan B, we urge you to consider that a woman's access to EC plays a critical role in preventing unintended pregnancy and reducing the need for abortion. We support the approval of Barr Laboratories' application. Thank you for your consideration of this request.

Sincerely,

Pat LeMond